The EU Marie Curie Actions has awarded almost EUR 4 million to AEGIS, an Initial Training Network, to be coordinated by the Helmholtz Zentrum, München. Prof dr Alex Domling, Drug Design-group of GRIP, is one of the consortium partners in this project.
The development of effective novel drugs - especially for rare and neglected diseases - is one of the biggest challenges of the upcoming decades, as illustrated by the recent Ebola outbreak. Moreover, European innovation in new drug registrations is dramatically falling behind compared to the US and Asia. The principal aim of the AEGIS is to implement the first comprehensive, intersectoral cross-disciplinary and structured curriculum for doctoral students in the European Research Area by establishing a unique training platform for the next generation of European researchers in early drug discovery. A significant added value is provided through networking with key European pharmaceutical companies. A key research aim of AEGIS is improving the efficiency and success of early stage drug development by combining innovative methods and techniques to tackle difficult but promising targets (i.e. protein-protein interactions), as potentially valuable drug targets are often neglected due to the high risk associated with their validation. The consortium joins leading academic and industry researchers in an open innovation environment for innovative drug development in Europe. It is supported by several additional partners and stakeholders in the field.
Dömling together with Carmolex BV will perform virtual drug discovery in this network using the unique platform Instant Chemistry & ANCHOR.QUERY.
The tender procedure for the
new Finance and HR operational management system has been finalized.
This week, the University of Groningen organized the 3 Minute Thesis Competition 2019: 12 PhD students presented their research to a non-specialist audience and a panel of judges in only three minutes, with just one slide. The winner of the UG #3MT...
Last week the Virtual Research Workspace of the CIT and the UMCG officially went into production.